Glaukos Announces 41 Percent First Quarter Sales Increase Fueled by Two Treatments

Published on April 30, 2026
ALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, yesterday released its first quarter financial results for the period ending March 31, 2026. Net sales of $150.6 million in the first quarter increased 41 percent on a reported basis, or 39 percent on a constant currency basis, compared with $106.7 million in the same period in 2025, the company reported.
Continue reading on website
Other news

Sterling Optical to Offer Complimentary Eye Exams to Certified Baseball Umpires for 2026 Season

April 30, 2026
NEW YORK—Emerging Vision, Inc. and its retail brand Sterling Optical announced they have launched a complimentary comprehensive eye exam promotion for certified baseball umpires at participating locations throughout the 2026 season in honor of May’s Health Vision Month. The first-of-its-kind promotion recognizes the visual demands placed on the baseball’s most overlooked participants, backed by a

New Contact Lens Update Spotlights the Benefits of Prescribing Contact Lenses for Children

April 30, 2026
WATERLOO, Ontario—The Centre for Ocular Research & Education (CORE) has published Issue 89 of Contact Lens Update, which focuses on contact lenses for a rapidly growing demographic in eyecare practices: the pediatric population. “Contact lenses are being increasingly prescribed to younger patients,” said Jill Woods, head of clinical research at CORE. “They can positively impact the lives of many c